ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,662.89
-0.22%
US Tech 100
19,166.80
-0.36%
다우존스 지수
41,953.32
-0.03%
Bitcoin
84,434.85
0.36%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Monte Rosa Therapeutics Inc (GLUE) 시세

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc (GLUE)

NASDAQ
7.06
0.36
(5.37%)
마감 21 3월 5:00AM
15분 지연
7.10
0.04
(0.57%)
시간외 거래: 8:33AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
7.10
매수가
7.15
매도가
7.19
거래량
2,475,190
6.345 일간 변동폭 7.31
3.32 52주 범위 12.40
market_cap
436.201M
전일 종가
6.70
개장가
6.46
최근 거래 시간
22
@
7.19
마지막 거래 시간
재정 규모
US$ 17,227,415
VWAP
6.96
평균 볼륨(3m)
689,873
발행 주식
61,436,740
배당수익률
-
주가수익률
-3.21
주당순이익(EPS)
-2.2
매출
-
순이익
-135.35M

Monte Rosa Therapeutics Inc 정보

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enable... Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.monterosatx.com.
본부
Wilmington, Delaware, USA
설립됨
-
Monte Rosa Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker GLUE. The last closing price for Monte Rosa Therapeutics was US$6.70. Over the last year, Monte Rosa Therapeutics shares have traded in a share price range of US$ 3.32 to US$ 12.40.

Monte Rosa Therapeutics currently has 61,436,740 shares in issue. The market capitalisation of Monte Rosa Therapeutics is US$411.63 million. Monte Rosa Therapeutics has a price to earnings ratio (PE ratio) of -3.21.

GLUE 최신 뉴스

추가 뉴스

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
14 시간 전
GLUE (5.37%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
15 시간 전
GLUE (5.37%)

Form 8-K - Current report
Edgar (US Regulatory)
17 시간 전
GLUE (5.37%)

Form 8-K - Current report
Edgar (US Regulatory)
10 1월 2025
GLUE (5.37%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 1월 2025
GLUE (5.37%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 1월 2025
GLUE (5.37%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.538.066971080676.577.196.126247716.57373207CS
40.538.066971080676.577.195.255787446.18161551CS
120.172.45310245316.937.465.156898736.2657107CS
260.9315.07293354946.1712.44.59517304418.41109209CS
520.243.498542274056.8612.43.329612628.04116023CS
156-6.6-48.175182481813.715.5252.444478277.73382634CS
260-14.9-67.72727272732245.562.444090529.31989024CS

GLUE - Frequently Asked Questions (FAQ)

What is the current Monte Rosa Therapeutics share price?
The current share price of Monte Rosa Therapeutics is US$ 7.10
How many Monte Rosa Therapeutics shares are in issue?
Monte Rosa Therapeutics has 61,436,740 shares in issue
What is the market cap of Monte Rosa Therapeutics?
The market capitalisation of Monte Rosa Therapeutics is USD 411.63M
What is the 1 year trading range for Monte Rosa Therapeutics share price?
Monte Rosa Therapeutics has traded in the range of US$ 3.32 to US$ 12.40 during the past year
What is the PE ratio of Monte Rosa Therapeutics?
The price to earnings ratio of Monte Rosa Therapeutics is -3.21
What is the reporting currency for Monte Rosa Therapeutics?
Monte Rosa Therapeutics reports financial results in USD
What is the latest annual profit for Monte Rosa Therapeutics?
The latest annual profit of Monte Rosa Therapeutics is USD -135.35M
What is the registered address of Monte Rosa Therapeutics?
The registered address for Monte Rosa Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Monte Rosa Therapeutics website address?
The website address for Monte Rosa Therapeutics is www.monterosatx.com.
Which industry sector does Monte Rosa Therapeutics operate in?
Monte Rosa Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PSTVPlus Therapeutics Inc
US$ 1.37
(168.10%)
357.75M
SAGSAG Holdings Ltd
US$ 1.15
(70.37%)
126.65M
OPTNOptiNose Inc
US$ 9.15
(52.50%)
2.17M
RGCRegencell Bioscience Holdings Ltd
US$ 44.06
(43.19%)
1.23M
NAOVNanoVibronix Inc
US$ 4.45
(36.50%)
1.06M
ELEVElevation Oncology Inc
US$ 0.2809
(-41.21%)
18.19M
BHILBenson Hill Inc
US$ 0.3969
(-38.50%)
1.47M
ADAPAdaptimmune Therapeutics PLC
US$ 0.28
(-37.65%)
14.05M
XHLDTEN Holdings Inc
US$ 0.99761
(-37.26%)
15.3M
LSELeishen Energy Holding Company Ltd
US$ 8.28
(-33.76%)
606.21k
PSTVPlus Therapeutics Inc
US$ 1.37
(168.10%)
357.75M
NVDANVIDIA Corporation
US$ 118.53
(0.86%)
247.95M
AGMHAGM Group Holdings Inc
US$ 0.077
(6.94%)
162.81M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.16
(0.25%)
147.13M
SAGSAG Holdings Ltd
US$ 1.15
(70.37%)
126.65M

GLUE Discussion

게시물 보기
Monksdream Monksdream 3 월 전
GLUE, under $7

👍️0
corncakes0 corncakes0 4 월 전
Hmm
👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE investors have been in what Cramer calls "the house of pain" for months. Many purchased this at $40,$50,$60,$70 per share. The company will be added to the long list of biotech failures once the inevitable FDA trial failure is confirmed.
👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE will soon be added to this list

https://www.fiercebiotech.com/special-reports/2023s-top-10-clinical-trial-flops

👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE trapped alot of "investors" earlier this week at 10+ all the way to 12.50/Share. It is cratering just as precipitously. Watch for less than 8....7.....6... in days to come.
👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE - No products. no revenues, massive losses, running out of cash. Millions of shares avaiable to short. Looking for $5/share
👍️0
Monksdream Monksdream 6 월 전
GLUE under $7
👍️0
Monksdream Monksdream 7 월 전
GLUE under $6
👍️0
Monksdream Monksdream 8 월 전
GLUE under $5
👍️0
Monksdream Monksdream 9 월 전
GLUE under $5
👍️0

최근 히스토리

NASDAQ
GLUE
Monte Rosa Therapeutics
NASDAQ
PRTC
PureTech Health
DOWI
DJSINVT
DJ US Select Investment ...
COIN
LGCCUST
LiveGreen Coin
NASDAQ
VERB
Verb Technology
TG
UCRH
Amundi Luxembourg
AQSE
RNO.GB
Renold
LSE
RI22
Bank Mont.28
LSE
0N4I
Danieli & C Officine Mec...
LSE
0WAR
Amundietf Gov Bd Euromts...
LSE
50WK
Abu Dhabi 51
AQSE
INDI.GB
Indus Gas Ltd Ord Gbp0 01
CSE
ACT
Aduro Clean Technologies
EU
SAMS
Samse
NASDAQ
IMUX
Immunic
DOWI
DJTIGST
DJ Industrial Goods and ...
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지